CL-108

CL-108 · Charleston Laboratories, Inc

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for CL-108, covering 2016-11-03 to 2023-03-22. Get the full timeline:

Most recent: Clinical Trial Update: A Controlled Study to Determine the Efficacy and Safety of CL-108 5 mg for Acute Pain and the Prevention of OINV [Phase 3]

See pricing